Outcome of interval debulking in advanced ovarian Cancer patients
Interval debulking and neoadjuvant chemotherapy have been used in management of advanced epithelial ovarian cancer for many years in order to achieve optimal residual disease and reduce surgical morbidity. The present study was conducted to evaluate the outcomes of advanced ovarian cancer patients t...
Saved in:
Main Authors: | Prapaporn Suprasert, Jittima Tiyanon, Chumnarn Kietpeerakool |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=67650899063&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/60188 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Outcome of interval debulking in advanced ovarian Cancer patients
by: Suprasert P., et al.
Published: (2014) -
Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin
by: Daranee Sirichaisutdhikorn, et al.
Published: (2018) -
Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin
by: Daranee Sirichaisutdhikorn, et al.
Published: (2018) -
Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma
by: Prapaporn Suprasert, et al.
Published: (2018) -
Survival outcomes of advanced and recurrent cervical cancer patients treated with chemotherapy: Experience of northern tertiary care hospital in Thailand
by: Kuanoon Boupaijit, et al.
Published: (2018)